ScholarIQanswers from OpenAlex

Autologous cell therapy in diabetes‑associated critical limb ischemia: From basic studies to clinical outcomes (Review)

PaperCitations, authors & open-access status

Autologous cell therapy in diabetes‑associated critical limb ischemia: From basic studies to clinical outcomes (Review) is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Autologous cell therapy in diabetes‑associated critical limb ischemia: From basic studies to clinical outcomes (Review) have?

ScholarIQcitation count

Autologous cell therapy in diabetes‑associated critical limb ischemia: From basic studies to clinical outcomes (Review) has 33 citations in the OpenAlex counts ScholarIQ stores.

When was Autologous cell therapy in diabetes‑associated critical limb ischemia: From basic studies to clinical outcomes (Review) published?

ScholarIQyear

Autologous cell therapy in diabetes‑associated critical limb ischemia: From basic studies to clinical outcomes (Review) has 2021 year in the ScholarIQ index.

What is the open-access status of Autologous cell therapy in diabetes‑associated critical limb ischemia: From basic studies to clinical outcomes (Review)?

ScholarIQoa status

Autologous cell therapy in diabetes‑associated critical limb ischemia: From basic studies to clinical outcomes (Review) has hybrid oa status in the ScholarIQ index.

What is the DOI of Autologous cell therapy in diabetes‑associated critical limb ischemia: From basic studies to clinical outcomes (Review)?

ScholarIQdoi

The DOI for Autologous cell therapy in diabetes‑associated critical limb ischemia: From basic studies to clinical outcomes (Review) is on the source record.

What is the PMID of Autologous cell therapy in diabetes‑associated critical limb ischemia: From basic studies to clinical outcomes (Review)?

ScholarIQpmid

The PMID for Autologous cell therapy in diabetes‑associated critical limb ischemia: From basic studies to clinical outcomes (Review) is on the source record.

What is the OpenAlex record for Autologous cell therapy in diabetes‑associated critical limb ischemia: From basic studies to clinical outcomes (Review)?

ScholarIQopenalex

The OpenAlex for Autologous cell therapy in diabetes‑associated critical limb ischemia: From basic studies to clinical outcomes (Review) is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial